This week the US Food and Drug Administration approved the release of fingolimod (trade name Gilenya®), the first oral medication for the treatment of remitting relapsing multiple sclerosis. Swedish Neuroscience Institute is proud to have participated in the pivotal clinical trial that led to the approval of Gilenya. Gilenya is a welcome addition to the set of medications available to patients living with MS. There are currently five injectable therapies and two intravenous therapies approved by the FDA for the treatment of MS. Although these treatments are very effective, many patients have been hoping for an oral alternative. Some patients are finding that they have “injection fatigue” or are running out of places to inject the medication. It is important to note, however, that not all patients should switch to Gilenya. Patients with stable disease should remain on their medications. Patients need to be informed of the risks associated with Gilenya, including slowed heart rate, increased blood pressure, difficulty breathing, abnormal liver function, and infection, and how these risks may apply to them. If you are wondering whether Gilenya is right for you, please ask your neurologist.
In my first video I talk about why I am doing this and what I hope the outcome will be. Please comment.
Most Recent Articles
The BRIDGES program provides job training and social opportunities for young adults with disabilities. Learn more.
Researchers at Swedish Cancer Institute are part of groundbreaking research with the potential to improve care for breast cancer patients everywhere.
A child psychiatrist from Swedish shares tips and answers questions about improving children’s resilience during the pandemic.
Check in each week in October to see the newest caregiver spotlight!
Sally Demetre, along with her husband John and mom, Doris Jensen, invest in cancer research at Swedish
Graduate student says thanks for lessons learned during internship with Swedish's LGBTQI+ initiative.
Keep this handy list of resources available throughout flu season so you can stay safe and healthy.
Lloyd Young and his wife, Linda, invest in Swedish's response to COVID-19
After illness or injury, rehabilitation caregivers help patients get life back on track
Meditation and mindfulness can improve your heart health. Learn more about how to easily adopt a meditation practice for your health.
Here’s what you need to know about flu shots and the COVID-19 vaccine